Lunit and National Cancer Institute Partner to Advance AI-Driven Cancer Research

 Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a collaboration with the National Cancer Institu...

April 11, 2025 | Friday | News
HNL Lab Medicine Partners with Northampton County to Offer Free Lead Testing for Children

HNL Lab Medicine, in partnership with Northampton County, is making it easier for families to access lead testing for children. Lead exposure remains a ser...

April 08, 2025 | Tuesday | News
NetraMark and Worldwide Clinical Trials Partner to Advance AI-Driven Precision in Global Clinical Trials

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company th...

April 04, 2025 | Friday | News
Merck and Hengrui Pharma Forge $1.97 Billion Global Partnership to Advance Novel Lp(a) Inhibitor for Cardiovascular Disease

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a ...

March 26, 2025 | Wednesday | News
Porton Advanced Partners with Eureka Therapeutics to Accelerate T-Cell Therapy Development

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

March 21, 2025 | Friday | News
BioSurfaces and Morphocell Partner to Advance Regenerative Medicine with Bio-Spun™ Technology

BioSurfaces, a leader in advanced nanofiber materials, and Morphocell Technologies, a regenerative medicine company, are pleased to announce a collaborat...

March 17, 2025 | Monday | News
Polyrizon Signs LOI to Develop Intranasal Psychedelic-Based Therapeutics

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development...

March 14, 2025 | Friday | News
Centivax Partners with Emery Pharma to Advance Potency Testing for Pan-Influenza Vaccine

Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration with ...

March 12, 2025 | Wednesday | News
Ionis and Ono Pharmaceutical Partner on Sapablursen for Polycythemia Vera with Exclusive Global Rights Agreement

 Ionis Pharmaceuticals, Inc. and Ono Pharmaceutical Co., Ltd (Ono), announced that the two companies have entered into a license agreement in whi...

March 12, 2025 | Wednesday | News
Optimizing Drug Launch Strategies with DelveInsight for Primary Immunodeficiency Therapies

To gain a competitive edge, the company partnered with DelveInsight to analyze competitor launch timelines, first-to-market companies, ...

March 11, 2025 | Tuesday | News
Nxera Pharma Signs Agreement with Viatris and Idorsia for Cenerimod Development and Commercialization in Japan, South Korea, and APAC

Nxera Pharma has entered an assignment agreement with Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Pharmaceuticals Ltd (&...

February 28, 2025 | Friday | News
Medigene and EpimAb Partner to Advance Off-the-Shelf TCR-TCE Therapies for Cancer

Medigene AG and EpimAb Biotherapeutics, Inc. (EpimAb), announced that the companies have entered a strategic co-development agreement to research and dev...

February 27, 2025 | Thursday | News
Renovaro Biosciences and BioSymetrics Merge to Advance AI-Driven Precision Medicine

Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyon...

February 27, 2025 | Thursday | News
HBM Alpha Therapeutics Partners with Global Business Partner to Advance CRH-targeting Therapy for Endocrine Disorders

HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed, announced a strategic collaboration and license...

February 26, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close